Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|May 14, 2014
Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulationSatoshi Morita, Hideharu Yamamoto, Yasuo Sugitani
The Patient|July 21, 2020
Quantitative Preferences for Lung Cancer Treatment from the Patients' Perspective: A Systematic ReviewYasuo Sugitani, Naoko Sugitani, Shunsuke Ono
Frontiers in Pharmacology|August 6, 2021
Patient Preferences for Attributes of Chemotherapy for Lung Cancer: Discrete Choice Experiment Study in JapanYasuo Sugitani, Kyoko Ito, Shunsuke Ono
Statistics in Medicine|April 20, 2023
Biomarker-based Bayesian randomized clinical trial design for identifying a target populationYasuo Sugitani, Satoshi Morita, Akiyoshi Nakakura, et al.
Therapeutic Innovation & Regulatory Science|July 28, 2021
Impact of Tumor Assessment Frequency on Statistical Power in Randomized Cancer Clinical Trials Evaluating Progression-Free SurvivalYuki Nakagawa, Takuya Yoshimoto, Shintaro Nakagawa, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Postmarketing Benefit-Risk Assessment for Erythropoiesis-Stimulating Agents Using a Health Care DatabaseYasuo Sugitani, Yukio Udagawa, Shinichi Matsuda, et al.
Clinical and Experimental Nephrology|May 17, 2022
Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims databaseTakashi Funatogawa, Yusuke Narita, Aya Tamura, et al.
Pageof 2